It's estimated that at least 12 million women in the United States are at an increased risk for breast cancer. This includes women over 50 with obesity or high-risk mammographic patterns. About 1 in 8 women will develop breast cancer at some point in their lives. A significant portion of this group, including those with strong family histories or BRCA1/BRCA2 mutations, have a higher lifetime risk"

Women at higher risk should be screened for breast cancer more frequently and may consider preventative measures like medication.
___

"....like medication"

& being the FDA approved prophylatic drugs are also toxic...#1 reason avoid taking them.

How about a non-toxic / tumor blood vessel killer ??

Very limited FDA approved drugs & with Hiv-MDR, just might be the fewest # of approved drugs.

I think prophylatic is only like 3 or 4 drugs.
Would LL even combo with those.
Dosen't seem like it would be.
Killing todays proph market.

( oh well...your services are no longer needed )

Either way, prophylatic is a massive market for Leronlimab....